Pharma giveth and pharma taketh; and sometimes, it does both at the exact same time. While faced with a public backlash over opioid addiction, pharma’s solution is now to create a vaccine that will allegedly stop the opioid addiction to heroin. The new vaccine has “shown promise in mice,” according to the journal Molecular Pharmaceutics, where the latest study has been publically touted as a “heroin vaccine.”
According to ibt.com
A protein in the vaccine sounds the alarm to the immune system so it fights off the heroin molecule, which would have otherwise slid under the radar.
If the drug user can no longer get high, the recovering addict may avoid relapsing, the researchers say.
“We believe that a heroin vaccine would be tremendously beneficial for people who have a heroin substance use disorder but have found difficulty in trying to quit,” first study author Candy Hwang said in a statement from the Scripps Research Institute.
“Our goal was to prepare a vaccine that could be advanced to clinical trials,” according to Hwang. “The heroin vaccine is one step closer to clinical evaluation.”
Pharmaceutical grade opioid addiction has become a national crisis. For many addicts, pharma’s version of opioids becomes too expensive and the addict has to move on to underground heroin markets. As per the usual script, pharma will waive all responsibility in the matter and simply invest in a vaccine that “solves the problem” which they created.
Pharma’s ingenious methods of shifting responsibility internally in profitable ways are uncanny but as transparent as it seems, the herd seems rather dumb to it all.